Cited by 943Bone Metabolism and DiseasesBone health and osteoporosis researchEstrogen and related hormone effects

Estrogen and the skeleton

Open access
Khosla, Sundeep, Oursler, Merry Jo, Monroe, David G.·2012·Trends in Endocrinology & Metabolism

Abstract

Estrogen is the major hormonal regulator of bone metabolism in women and men. Therefore, there is considerable interest in unraveling the pathways by which estrogen exerts its protective effects on bone. Although the major consequence of the loss of estrogen is an increase in bone resorption, estrogen deficiency is associated with a gap between bone resorption and formation, indicating that estrogen is also important for maintaining bone formation at the cellular level. Direct estrogen effects on osteocytes, osteoclasts, and osteoblasts lead to inhibition of bone remodeling, decreased bone resorption, and maintenance of bone formation, respectively. Estrogen also modulates osteoblast/osteocyte and T-cell regulation of osteoclasts. Unraveling these pleiotropic effects of estrogen may lead to new approaches to prevent and treat osteoporosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tem.2012.03.008

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Excessive resorption by osteoclasts without the corresponding amount of neoformed bone by osteoblasts contributes to bone loss and osteoporosis.

    “For example, excessive resorption by osteoclasts without the corresponding amount of nerformed bone by osteoblasts contributes to bone loss and osteoporosis [16]”
  • Estrogen plays crucial roles for bone tissue homeostasis.

    “Estrogen plays crucial roles for bone tissue homeostasis; the decrease in estrogen level at menopause is the main cause of bone loss and osteoporosis [16].”
  • The decrease in estrogen level at menopause is the main cause of bone loss and osteoporosis.

    “Estrogen plays crucial roles for bone tissue homeostasis; the decrease in estrogen level at menopause is the main cause of bone loss and osteoporosis [16].”
  • The systemic factors important to the maintenance of bone homeostasis include parathyroid hormone (PTH), calcitonin, 1,25-dihydroxyvitamin D3 (calcitriol), glucocorticoids, androgens, and estrogens.

    “The systemic factors which are important to the maintenance of bone homeostasis include parathyroid hormone (PTH), calcitonin, 1,25-dihydroxyvitamin D3 (calcitriol), glucocorticoids, androgens, and estrogens [16, 147–150].”
  • Estrogen suppresses osteoclast formation and activity.

    “The estrogen suppresses the osteoclast formation and activity as well as induces osteoclast apoptosis [16, 76, 104, 154].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Khosla, S., Oursler, M. J., & Monroe, D. G.
Affiliations
Mayo Clinic (US)
Corresponding author
Khosla, Sundeep
Venue
Trends in Endocrinology & Metabolism
Publisher
Elsevier BV
Published
2012-11
Volume
23
Issue
11
Pages
576-581
ISSN
1043-2760 (ISSN-L)
OpenAlex
W2119221073
Cited by
943
References
56
Citations by year
2026: 99 · 2025: 106 · 2024: 87 · 2023: 130 · 2022: 87 · 2021: 99 · 2020: 85 · 2019: 46 · 2018: 43 · 2017: 40 · 2016: 30 · 2015: 36 · 2014: 25 · 2013: 23 · 2012: 6
FWCI
2.63
Type
journal article
Language
en
Open access
Locations
  • Trends in Endocrinology and Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Institute on Aging (P01AG004875, AG004875)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR-027065, R01AR027065)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
Keywords
estrogen, bone metabolism, estrogen deficiency, bone resorption, bone formation, bone remodeling, osteoblasts, osteocytes, osteoclasts, osteoporosis prevention, osteoporosis treatment
MeSH terms
Animals, Bone and Bones, Estrogens, Female, Humans, Male, Osteoblasts, Osteoclasts, Osteocytes, Osteoporosis, T-Lymphocytes, Bone Remodeling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review